Tom Willgoss

531 total citations
12 papers, 247 citations indexed

About

Tom Willgoss is a scholar working on Cognitive Neuroscience, General Health Professions and Clinical Psychology. According to data from OpenAlex, Tom Willgoss has authored 12 papers receiving a total of 247 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cognitive Neuroscience, 3 papers in General Health Professions and 3 papers in Clinical Psychology. Recurrent topics in Tom Willgoss's work include Autism Spectrum Disorder Research (4 papers), Family and Disability Support Research (3 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Tom Willgoss is often cited by papers focused on Autism Spectrum Disorder Research (4 papers), Family and Disability Support Research (3 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Tom Willgoss collaborates with scholars based in United Kingdom, United States and Switzerland. Tom Willgoss's co-authors include Antoine Regnault, Skye Barbic, Michelle L. Krishnan, Meghan T. Miller, Lynne M. Bird, Julie McCormack, Dawn Phillips, Rebecca D. Burdine, Terry Jo Bichell and Richard Houghton and has published in prestigious journals such as Nature Reviews Drug Discovery, Journal of the American Academy of Child & Adolescent Psychiatry and Journal of Autism and Developmental Disorders.

In The Last Decade

Tom Willgoss

11 papers receiving 243 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tom Willgoss United Kingdom 5 57 52 38 32 32 12 247
Joanna Szabo Canada 6 58 1.0× 76 1.5× 86 2.3× 21 0.7× 19 0.6× 8 266
Marc A. Emerson United States 10 46 0.8× 30 0.6× 69 1.8× 17 0.5× 42 1.3× 26 444
Miriam K. Depping Germany 8 29 0.5× 69 1.3× 30 0.8× 44 1.4× 10 0.3× 14 298
Anna Baranowska Poland 12 55 1.0× 48 0.9× 16 0.4× 12 0.4× 22 0.7× 34 309
Louise Newton United States 10 47 0.8× 40 0.8× 16 0.4× 33 1.0× 47 1.5× 23 322
Kate Tsiplova Canada 11 74 1.3× 108 2.1× 53 1.4× 56 1.8× 25 0.8× 23 372
Jessica Berg United States 9 96 1.7× 39 0.8× 67 1.8× 33 1.0× 117 3.7× 46 316
Sara Horton United States 9 53 0.9× 33 0.6× 32 0.8× 15 0.5× 39 1.2× 17 299
Ian Whitmarsh United States 7 23 0.4× 129 2.5× 37 1.0× 43 1.3× 41 1.3× 12 253
Linda Rainey Netherlands 14 56 1.0× 128 2.5× 53 1.4× 14 0.4× 29 0.9× 29 515

Countries citing papers authored by Tom Willgoss

Since Specialization
Citations

This map shows the geographic impact of Tom Willgoss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Willgoss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Willgoss more than expected).

Fields of papers citing papers by Tom Willgoss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Willgoss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Willgoss. The network helps show where Tom Willgoss may publish in the future.

Co-authorship network of co-authors of Tom Willgoss

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Willgoss. A scholar is included among the top collaborators of Tom Willgoss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Willgoss. Tom Willgoss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Oehrlein, Elisabeth, Barry Lewis, Jim Elliott, et al.. (2025). Patient Engagement and Patient Experience Data in Regulatory Review and Health Technology Assessment: Where Are We Today?. Therapeutic Innovation & Regulatory Science. 59(4). 737–752.
2.
Gibbons, Elizabeth, et al.. (2023). Qualitative Exploration in Exit Interviews of Changes Observed in Clinical Trials for Individuals with Autism Spectrum Disorder Without Intellectual Disability. Patient Related Outcome Measures. Volume 14. 313–335. 3 indexed citations
3.
4.
5.
Duong, Tina, Hannah Staunton, Ling Gao, et al.. (2022). A Patient-Centered Evaluation of Meaningful Change on the 32-Item Motor Function Measure in Spinal Muscular Atrophy Using Qualitative and Quantitative Data. Frontiers in Neurology. 12. 770423–770423. 13 indexed citations
6.
Romero, Heather, Paul O’Donohoe, Kathleen W. Wyrwich, et al.. (2022). Recommendations for the Electronic Migration and Implementation of Clinician-Reported Outcome Assessments in Clinical Trials. Value in Health. 25(7). 1090–1098. 4 indexed citations
7.
Krishnan, Michelle L., Elizabeth Berry‐Kravis, Jamie K. Capal, et al.. (2021). Clinical trial strategies for rare neurodevelopmental disorders: challenges and opportunities. Nature Reviews Drug Discovery. 20(9). 653–654. 8 indexed citations
8.
Willgoss, Tom, Michelle L. Krishnan, Meghan T. Miller, et al.. (2020). Measuring What Matters to Individuals with Angelman Syndrome and Their Families: Development of a Patient-Centered Disease Concept Model. Child Psychiatry & Human Development. 52(4). 654–668. 38 indexed citations
9.
Houghton, Richard, Brigitta U. Monz, Kiely Law, et al.. (2019). Psychometric Validation of the Autism Impact Measure (AIM). Journal of Autism and Developmental Disorders. 49(6). 2559–2570. 14 indexed citations
10.
Trigg, Andrew, Eric K. H. Chan, Helen Kitchen, et al.. (2019). Psychometric Validation of the Hepatitis C Symptom and Impact Questionnaire (HCV-SIQv4) in a Diverse Sample of Adults with Chronic Hepatitis C Virus Infection Treated with an Interferon-free Simeprevir-containing Regimen. Journal of health economics and outcomes research. 6(2). 1–19. 1 indexed citations
11.
Regnault, Antoine, Tom Willgoss, & Skye Barbic. (2018). Towards the use of mixed methods inquiry as best practice in health outcomes research. Journal of Patient-Reported Outcomes. 2(1). 158 indexed citations
12.
Willgoss, Tom, Lisa Squassante, Kevin Sanders, et al.. (2018). 5.14 Psychometric Properties of a Novel Vineland-II 2-Domain Composite Score to Assess Social Communication and Social Interaction in ASD. Journal of the American Academy of Child & Adolescent Psychiatry. 57(10). S231–S232. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joanna Szabo Breakdown of academic impact, for papers by Marc A. Emerson Breakdown of academic impact, for papers by Miriam K. Depping Breakdown of academic impact, for papers by Anna Baranowska Breakdown of academic impact, for papers by Louise Newton Breakdown of academic impact, for papers by Kate Tsiplova Breakdown of academic impact, for papers by Jessica Berg Breakdown of academic impact, for papers by Sara Horton Breakdown of academic impact, for papers by Ian Whitmarsh Breakdown of academic impact, for papers by Linda Rainey
Rankless by CCL
2026